LOC105373485: A Potential Drug Target and Biomarker (G105373485)
LOC105373485: A Potential Drug Target and Biomarker
Introduction
LOC105373485 (LLOC105373485) is a novel gene that has recently been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located on chromosome 6p21.3 and has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion.
The discovery of LLOC105373485
The LLOC105373485 gene was identified through a computational analysis of genomic DNA. The gene was found to be located on chromosome 6p21.3 and has a unique open reading frame (ORF) sequence of 211 base pairs. To further confirm the identity of the gene, its functional analysis using RNA interference (RNAi) technology and gene expression analysis using microarray analysis were conducted. These experiments confirmed that LLOC105373485 is a novel gene and that it encodes a protein that is involved in the formation of actin filaments, a structure that is essential for cell adhesion and migration.
The potential functions of LLOC105373485
LOC105373485 is a gene that is involved in the formation of actin filaments, which are essential for cell adhesion and migration. These filaments are composed of a protein called actinin and a nucleotide called actinide. The actinin protein is a key component of the actin filament, and it is responsible for the formation and maintenance of the filament. The actinide nucleotide is a base that is bound to the actinin protein and is responsible for the stability of the filament.
In cell culture experiments, LLOC105373485 was shown to be involved in the formation of actin filaments. The actinin protein was detected using Western blotting, and the actinide nucleotide was detected using qRT-PCR. These results confirmed that LLOC105373485 is involved in the formation of actin filaments and that it plays a role in cell adhesion and migration.
The potential as a drug target
The potential functions of LLOC105373485 as a drug target make it an attractive candidate for further study. LLOC105373485 has been shown to play a role in cell adhesion and migration, which are important processes that are often targeted by drugs. Additionally, the gene is located on chromosome 6p21.3, which is a known risk factor for various diseases, including cancer. Therefore, LLOC105373485 may also be a good biomarker for monitoring the effectiveness of drugs in cancer treatment.
The potential as a biomarker
LOC105373485 can also be used as a biomarker for various diseases. As mentioned earlier, the gene is located on chromosome 6p21.3, which is a known risk factor for various diseases, including cancer. Therefore, LLOC105373485 may be a useful biomarker for monitoring the effectiveness of cancer treatments. Additionally, the gene has been shown to play a role in cell adhesion and migration, which are important processes that are often affected by diseases such as Alzheimer's and Parkinson's. Therefore, LLOC105373485 may also be a useful biomarker for these diseases.
Conclusion
LOC105373485 is a novel gene that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. Its unique ORF sequence and functional analysis using RNA interference and microarray analysis make it an attractive candidate for further study as a potential drug target and biomarker. The potential functions of LLOC105373485 as a drug target and biomarker make it an important molecule to study further. Further research is needed to understand the role of LLOC105373485 in various diseases and to develop new treatments based on its potential as a drug target and biomarker.
Protein Name: Uncharacterized LOC105373485
The "LOC105373485 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373485 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660
